Objective: To asses the efficacy of hydrochlorothiazide on 24-h blood pressure (BP) control.Methods: Review of all the randomized trials that assessed.

Slides:



Advertisements
Similar presentations
11/2/ Implications of ASCOT Results for ALLHAT Conclusions ALLHAT.
Advertisements

1 SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY (ANBP-2) Enalapril/ACEI vs. HCTZ, n = 6,083 Randomized, open-label (blinded endpoint review) All CV events.
The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.
The ONTARGET Trial Reference The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:15.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Pharmacological Treatment of Hypertension Update 2012.
Hypertension in the Elderly
WHEN SHOULD ONE INITIATE SUCCESSIVE ANTIHYPERTENSIVE DRUGS? Henry R. Black M.D. RUSH University Medical Center Chicago, IL June 15, 2005.
1 The JNC 7 recommendations for initial or combination drug therapy are based on sound scientific evidence.
CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
Randomized, double-blind, multicenter, controlled trial.
DR. IDOWU AKOLADE EDM DIVISION LUTH
Selection of Antihypertensive Drug. BP ClassificationSystolic BP, mm Hg Diastolic BP, mm Hg Normal
Daily Dilemmas in Hypertension Management. Objectives Review the impact of hypertension on society Review the impact of hypertension on society Review.
Is It the Achieved Blood Pressure or Specific Medications that Make a Difference in Outcome, or Is the Question Moot? William C. Cushman, MD Professor,
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
Systolic hypertension not an isolated problem Michael Weber, MD Professor of Medicine Associate Dean Downstate College of Medicine State University of.
Combination Therapy for Hypertension Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology December 3, 2008Journal Watch.
1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.
1 Can One Evaluate An Outcomes Claim Based On An Active Controlled Study? Pfizer Response Cardiovascular and Renal Drugs Advisory Committee Rockville,
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Copyleft Clinical Trial Results. You Must Redistribute Slides HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)
HvC Comparative Effectiveness Project Groups 5 and 6
Enrollment, Randomization, and Follow-up of Study Participants ADVANCE Collaborative Group. N Engl J Med 2008;358:
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
7/27/2006 Outcomes in Hypertensive Black and Nonblack Patients Treated with Chlorthalidone, Amlodipine, and Lisinopril* * Wright JT, Dunn JK, Cutler JA.
Beckett N, Peters R, Tuomilehto J, et al. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment.
Efficacy and Comparability of Thiazide-type Diuretics
Why fixed-dose combinations in hypertension? Barrios V, Escobar C. Integrated Blood pressure Control. 2010: Combination therapy is needed when.
Pre-ALLHAT Drug Use IMS Health NDTI, Year % of Treated Patients on Medication CCBs Beta Blockers Diuretics ACE Inhibitors.
WA2: High Blood Pressure Medicine It can save your life, but can you afford it?
Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial.
1 ALLHAT Antihypertensive Trial Results by Baseline Diabetic Status January 28, 2004.
JNC 7 血壓分期. 血壓分期 JNC 7 : 1. 增加高血壓前期 2.Stages 2 及 3 高血壓被合併 JNC 7, 2003.
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
Guidelines recommend, as first-line treatment for hypertension, a diuretic or the combination of diuretic ± ACE inhibitor. Prevention of Stroke in Patients.
Canagliflozin Cardiovascular Safety. 2 Potential CV protection pathways of SGLT2i Diab Vasc Dis Res Mar;12(2):
Wald DS, et al. Am J Med 2009;122: Details of the 42 Trials Included in the Meta-analysis - Part I Wald DS, et al. Am J Med 2009;122:
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.
Are the European Practice Guidelines for the Management of Arterial Hypertension (2007) adapted to the old and the frail? Anette Hylen
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/AHA 2011 Expert Consensus Document on Hypertension.
Cardiovascular Disease and Antihypertensives The RENAAL Trial Reference Brunner BM, and the RENAAL study group. Effects of losartan on renal and cardiovascular.
Evidence based medicine Antihypertensive drugs in the elderly Group 1 and 6 -Heba Othman -Heba Sabry -Reem Ahmed -Dina Reda -Dalia El Magraby.
Blood Pressure and Lipid Trials: Rationale, Importance and Design
State University of New York
The SPRINT Research Group
THE FACT: A Guideline Based Medication in the Management of Hypertension JENNIFER OKPALAEZE.
Blood Pressure and Age in Controlling Hypertension
Copyright © 2005 American Medical Association. All rights reserved.
Health and Human Services National Heart, Lung, and Blood Institute
Copyright © 2011 American Medical Association. All rights reserved.
United States Preventive Services Task Force: Recommendations for ABPM
Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH): Design Randomized, double-blind.
Progress and Promise in RAAS Blockade
Mean BP from initial visit to four years
Hypertension Guidelines
ALLHAT: What Outcomes Would Have Been Expected?
The Hypertension in the Very Elderly Trial (HYVET)
VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.
Table of Contents Why Do We Treat Hypertension? Recommendation 5
The Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Study was a double-blind, randomized, placebo-controlled study.
The following slides highlight a report by Dr
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
Pharmacological Treatment of Hypertension Update 2012
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.
Presentation transcript:

Objective: To asses the efficacy of hydrochlorothiazide on 24-h blood pressure (BP) control.Methods: Review of all the randomized trials that assessed 24-h BP with hydrochlorothiazide (HCTZ) compared with other antihypertensive drugs. Meta-analysis of: -14 studies of HCTZ dose 12.5 to 25 mg, -5 studies of HCTZ dose 50 mg. No evidence to support the use of hydrochlorothiazide for 24-h blood pressure control 1. Messerli FH et al. J Am Coll Cardiol. 2011;57:

Efficacy of hydrochlorothiazide, assessed by 24-h ABPM 1 Efficacy of hydrochlorothiazide, assessed by 24-h ABPM 1 (Adapted from Messerli FH et al. J Am Coll Cardiol. 2011;57: ) Compared with hydrochlorothiazide (HCTZ) dose 12.5 to 25 mg, P< for other antihypertensive drugs, as assessed by 24-h ambulatory blood pressure (ABP) monitoring. Bars = 95% confidence intervals N = number of studies ACE = angiotensin-converting enzyme ARBs = angiotensin-receptor blockers 1. Messerli FH et al. J Am Coll Cardiol. 2011;57: HCTZ: inferior 24-h BP control N=14 N=5 N=3 N=5 N= BP Reduction (mm Hg) ACE inhibitors ARBsBeta Blockers Calcium Antagonists HCTZ Systolic BP Diastolic BP

“Not all diuretics are equal” HCTZ mg/day does not reduce stroke and heart attack, or death. 2,3 The diuretics shown to reduce cardiovascular morbidity and mortality are chlorthalidone in SHEP and ALLHAT, and indapamide in HYVET, PROGRESS, and ADVANCE 2. Gaciong Z, Symonides B. Expert Opin. Pharmacother. 2010;11: Kaplan NM. Hypertension. 2009;54: Beckett NS, Peters R, Fletcher AE, et al. N Engl J Med. 2008;358: PROGRESS Collaborative Group. Lancet. 2001;358:1033– ADVANCE Collaborative Group. Lancet. 2007;370: Total mortality Fatal or nonfatal stroke Heart failure Fatal stroke -39% -30% -64% -21% Cardiovascular mortality Renal events Total mortality -14% -18% -21% Stroke -43%

The efficacy on 24-h blood pressure control of HCTZ at its usual daily doses, of 12.5 to 25 mg/day is inferior to that of all other antihypertensive drug classes. 1 There are no data showing that HCTZ mg/day reduces heart attack and stroke or death. 2 The authors of the meta-analysis concluded that: CONCLUSIONS 1. Messerli FH et al. J Am Coll Cardiol. 2011;57: Gaciong Z, Symonides B. Expert Opin. Pharmacother. 2010;11: “if a clinical indication calls for a thiazide-type diuretic, chlorthalidone or indapamide remain the drugs of choice”. “if a clinical indication calls for a thiazide-type diuretic, chlorthalidone or indapamide remain the drugs of choice”. 1